Skip to main content
. 2020 Oct 8;12(4):449–456. doi: 10.4103/jpbs.JPBS_294_19

Table 1.

Susceptibility pattern of Escherichia coli

Antibiotics Test done (td) Resistant
95% CI resistant Sensitive
95% CI sensitive Test not done (nd)
N (%) N (%)
Penicillin 2 2 (100) 34.2–100 0 (0) 0 94
Ampicillin 78 69 (88.46) 79.50–93.81 9 (11.54) 6.19–20.50 51
Augmentin 33 14 (42.42) 27.24–59.19 19 (57.58) 40.81–72.76 95
Carbenicillin 0 0 0 0 0 115
Aztreonam 22 3 (13.64) 4.75–33.33 19 (86.36) 66.67–95.25 92
Imipenem 82 1 (1.22) 0.22–6.59 81 (98.78) 93.41–99.78 48
Meropenem 18 0 (0) 0 18 (100 ) 82.41–100 96
Piperacillin 1 0 (0) 0 1 (100) 20.65–100 128
Tazocin (Zosyn) 38 4 (10.53) 4.17–24.13 34 (89.47) 75.87–95.83 90
Cephalexin 44 42 (95.45) 84.87–98.74 2 (4.55) 1.26–15.13 84
Cefoxitin 22 16 (72.73) 51.85–86.85 6 (27.27) 13.15–48.15 125
Cefuroxime 23 7 (30.43) 15.60–50.87 16 (69.57) 49.13–84.40 56
Ceftriaxone 39 18 (46.15) 31.57–61.43 21 (53.85) 38.57–68.43 57
Ceftazidime 13 0 (0) 13 (100.0) 77.19–100 115
Cefepime 26 8 (30.77) 16.50–49.99 18 (69.23) 50.01–83.50 102
Amikacin 81 3 (3.70) 1.27–10.33 78(96.30) 89.67–98.73 49
Gentamicin 29 4 (13.79) 5.50–30.56 25 (86.21) 69.44–94.50 99
Ciprofloxacin 61 30 (49.18) 37.06–61.40 31(50.82) 38.60–62.94 67
Levofloxacin 1 0 (0) 0 1(100.00) 20.65–100.0 45
Norfloxacin 53 28 (52.83) 39.66–65.62 25 (47.17) 34.38–60.34 66
Erythromycin 1 1 (100.00) 20.65–100 0 (0) 0 128
Clindamycin 1 1 (100.00) 20.65–100 0 (0) 0 128
Vancomycin 1 0 (0) 0 1 (100.00) 20.65–100.00 128
Linezolid 1 0 (0) 0 1 (100.00) 20.65–100.00 128
Tigecycline 4 0 (0) 0 4 (100.00) 51.01–100 125
Colistin 3 0 (0) 0 3 (100.00) 43.85–100 126
Nitrofurantoin 112 11 (9.82) 5.57–16.73 101 (90.18) 83.72-94.43 17
TMP-SMX 107 61 (57.01) 47.55–65.99 46 (42.99) 34.01–52.45 22

N = frequency, CI = confidence interval, TMP-SMX = Trimethoprim and sulfamethoxazole, td = respective antibiotic tested against E. coli, nd = respective antibiotic was not tested against E. coli